摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,4’-二羟基苯偶酰 | 33288-79-8

中文名称
4,4’-二羟基苯偶酰
中文别名
4,4'-二羟基苯偶酰;4,4'-二羟基二苯基乙二酮
英文名称
4,4'-dihydroxybenzil
英文别名
1,2-bis(4-hydroxyphenyl)ethane-1,2-dione;4,4’-dihydroxybenzil;4,4′-dihydroxy-benzil;4,4'-dihydroxydiphenyl ethylenedione
4,4’-二羟基苯偶酰化学式
CAS
33288-79-8
化学式
C14H10O4
mdl
——
分子量
242.231
InChiKey
FMYXOBBPXQZKKY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    235 °C(Solv: water (7732-18-5))
  • 沸点:
    500.4±35.0 °C(Predicted)
  • 密度:
    1.366±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    74.6
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2914501900
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    室温下,应保存于惰性气体中。

SDS

SDS:8ad1dbcc335f29fef3e075a9abc773d0
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    (Z)-Tetraphenylbut-2-ene-1,4-diones: facile synthesis, tunable aggregation-induced emission and fluorescence acid sensing
    摘要:
    一种简便的方法来合成立体特异性的(Z)-芳基功能化1,4-烯酮已被提出。
    DOI:
    10.1039/c7tc00173h
  • 作为产物:
    描述:
    参考文献:
    名称:
    Hyperbranched Polyphenylquinoxalines from Self-Polymerizable AB2 and A2B Monomers
    摘要:
    A self-polymerizable AB(2) monomer, 2,3-bis(4-hydroxyphenyl)-6-fluoroquinoxaline, and an A(2)B monomer, 2,3-bis(4-fluorophenyl)-6-(4-hydroxyphenoxy)quinoxaline, were prepared and polymerized to afford phenol-terminated and aryl fluoride terminated, hyperbranched polyphenylquinoxalines (HPPQs), respectively. MALDI-TOF analysis showed that intramolecular cyclization was a dominant process for the low molecular weight portion during the polymerizations. After isolation and complete dryness, the phenol-terminated HPPQ 1 was only soluble in strong organic acids, while the aryl fluoride terminated HPPQ 2 was soluble in most common organic solvents. HPPQ 1 was treated with allyl bromide to afford an allyl ether terminated HPPQ 3, which was also soluble in most organic solvents. Intrinsic viscosity measurements and SEC analysis indicated that HPPQ 2 had a much higher M-w and a much broader molecular weight distribution (PDI similar to 60) than HPPQ 1 and HPPQ 3 (PDI similar to 4). The results also suggested that HPPQ 1 formed aggregates in solution and that HPPQ 2 had a much more extended and open conformation. All the HPPQs, which were highly fluorescent, had UV absorption maxima near 375 nm in THF. However, the wavelength of their emission maxima, which ranged from 424 to 466 nm, depended on their end groups.
    DOI:
    10.1021/ma0489467
点击查看最新优质反应信息

文献信息

  • Vasculostatic agents and methods of use thereof
    申请人:Wrasidlo Wolfgang
    公开号:US20050282814A1
    公开(公告)日:2005-12-22
    Compositions and methods and are provided for treating disorders associated with compromised vasculostasis. Invention methods and compositions are useful for treating a variety of disorders including for example, stroke, myocardial infarction, cancer, ischemia/reperfusion injury, autoimmune diseases such as rheumatoid arthritis, eye diseases such as retinopathies or macular degeneration or other vitreoretinal diseases, inflammatory diseases, vascular leakage syndrome, edema, transplant rejection, adult/acute respiratory distress syndrome (ARDS), and the like.
    提供了用于治疗与血管稳态受损相关的疾病的组合物和方法。发明的方法和组合物可用于治疗各种疾病,包括中风、心肌梗死、癌症、缺血/再灌注损伤、类风湿性关节炎等自身免疫疾病、眼部疾病如视网膜病变或黄斑变性或其他玻璃体视网膜疾病、炎症性疾病、血管渗漏综合征、肿、移植排斥反应、成人/急性呼吸窘迫综合征(ARDS)等。
  • Glycoluril core molecules for combinatorial libraries
    申请人:Rebek, Jr. Julius
    公开号:US06939973B1
    公开(公告)日:2005-09-06
    The present invention provides novel glycoluril derivatives for use as core molecules in combinatorial chemistry. Core molecules of the present invention can contain from one to six building blocks. Preferred building blocks are substituted amine radicals. Combinatorial libraries containing such core molecules are also provided.
    本发明提供了用作组合化学中核心分子的新型甘生物。本发明的核心分子可以包含从一个到六个构建块。首选的构建块是取代胺基团。还提供了含有这种核心分子的组合式文库。
  • Plasminogen activator inhibitor antagonists
    申请人:Corvas International INC
    公开号:US06677473B1
    公开(公告)日:2004-01-13
    Compounds and pharmaceutical compositions useful as plasminogen activator inhibitor (PAI) antagonists are provided. In particular, methods of antagonizing PAI with substituted and unsubstituted aryl and heteroaryl ethers and thioethers, benzils, benzyl ethers, benzoate esters, sulfones and benzophenones are provided.
    提供了一种作为纤溶酶原激活剂抑制剂(PAI)拮抗剂的化合物和药物组合物。特别是,提供了用取代和未取代的芳基和杂芳基醚和醚、苯偶姻、苄基醚、苯甲酸酯、磺酰和苯甲酮拮抗PAI的方法。
  • [EN] CARBON MONOXIDE RELEASING NORBORNENONE COMPOUNDS<br/>[FR] COMPOSÉS DE NORBORNÉNONE LIBÉRANT DU MONOXYDE DE CARBONE
    申请人:SAMMUT IVAN ANDREW
    公开号:WO2017095237A1
    公开(公告)日:2017-06-08
    The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.
    本发明提供了在生理条件或pH触发下能够释放一氧化碳的有机化合物,以及将这种化合物用于调节细胞、组织或器官,例如,在移植事件中保护免受缺血性损伤的使用方法。
  • [EN] DENTAL COMPOSITION CONTAINING POLYOXOMETALATES, PROCESS OF PRODUCTION AND USE THEREOF<br/>[FR] COMPOSITION DENTAIRE CONTENANT DES POLYOXOMÉTALATES, PROCÉDÉS DE PRODUCTION ET D'UTILISATION DE LADITE COMPOSITION
    申请人:3M INNOVATIVE PROPERTIES CO
    公开号:WO2015034977A1
    公开(公告)日:2015-03-12
    The invention relates to a curable composition for dental use comprising polyoxymetalates and/or derivatives thereof in an amount of at least about 5 wt.-% with respect to the weight of the composition.
    该发明涉及一种可治疗的牙科用组合物,其包括聚氧属酸盐和/或其衍生物,其在组合物的重量上占至少约5重量百分比。
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S,5R,5''R)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4R,5S)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 黄子囊素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-白藜芦醇3-O-beta-D-葡糖苷酸 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1-(3-甲基-2-萘基)-2-(2-萘基)乙烯 顺式-1,2-双(三甲基硅氧基)-1,2-双(4-溴苯基)环丙烷 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 非洲李(PRUNUSAFRICANA)树皮提取物 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀杂质7 阿托伐他汀杂质5 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 锌(II)(苯甲醛)(四苯基卟啉) 银松素 铜酸盐(5-),[m-[2-[2-[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[2-[2-(羧基-kO)苯基]二氮烯基-kN1]-4,5-二氢-3-甲基-5-(羰基-kO)-1H-吡唑-1-基]-2-硫代苯基]乙烯基]-3-硫代苯基]氨基]-6-(苯基氨基)-1,3,5-三嗪-2-基]氨基]-2-硫代苯基]乙烯基]-3-硫代 铒(III) 离子载体 I 铀,二(二苯基甲酮)四碘- 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯

相关功能分类